Aevitas Wealth Management’s Editas Medicine EDIT Stock Holding History

Aevitas Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-500	Closed	-$12K	–	167
2019 Q1	$12K	Hold	500	–	–	0.01%	289
2018 Q4	$11K	Hold	500	–	–	0.01%	289
2018 Q3	$16K	Hold	500	–	–	0.01%	305
2018 Q2	$18K	Hold	500	–	–	0.02%	286
2018 Q1	$17K	Hold	500	–	–	0.02%	272
2017 Q4	$15K	Buy	+500	New	+$12.6K	0.01%	282

Other funds holding EDIT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Aevitas Wealth Management's EDIT Position: Q2 2019 in Review

Aevitas Wealth Management sold out of Editas Medicine (EDIT) in Q2 2019, closing a stake of 500 shares — an estimated $12K sold.

Aevitas Wealth Management first reported a position in EDIT in Q4 2017 and held it in 6 quarters. The position peaked at $18K in Q2 2018. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2019.

Aevitas Wealth Management reported no remaining Editas Medicine position as of Q2 2019 after selling out during the quarter.
Aevitas Wealth Management sold 500 Editas Medicine shares in Q2 2019, an estimated $12K.
Aevitas Wealth Management first reported a position in Editas Medicine in Q4 2017 and held it in 6 quarters.
Aevitas Wealth Management's Editas Medicine position peaked at $18K in Q2 2018.
193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2019.

Based on Aevitas Wealth Management's 13F filing for Q2 2019, filed 26 Jul 2019.